About 10 years ago, we decided to make the application of high-precision machining technology and quality control capabilities, cultivated in parts supply for F1 Racing Cars and prototype parts supply field for new commercial car development, one of the pillar of our next-generation business. We have been allocating internal resources to this end. In addition to manufacturing final medical device products, we also undertake the production of parts, particularly micro-machined components, not limited to the medical field, which has been our core business for the last four decades. We have developed special forceps for transnasal neurosurgery and are currently lending samples to doctors in Japan, collecting wide-ranging evaluation reports. Negotiations for the OEM supply of dissectors to the company in the US are progressing and will soon begin shipments. Additionally, OEM negotiations for neurosurgical forceps for the same group company in Japan are about to start. As for micro-machined components, although they are for demonstration purposes, we have tract record of supplying them for impeller of transcutaneous ventricular assist device.
